Managing Partnerships with CROs 2011

Venue: Holiday Inn Bloomsbury

Location: London, United Kingdom

Event Date/Time: Oct 03, 2011 End Date/Time: Oct 04, 2011
Report as Spam


SMi present their 3rd annual conference…
Managing Partnerships with CROs
Monday 3rd and Tuesday 4th October 2010
Holiday Inn Bloomsbury, London, UK

SMi Group proudly announces its 3rd annual conference on Managing Partnerships with CROs, due to take place on 3rd and 4th October 2011 in London.
The pharmaceutical and biopharmaceutical industry is facing enormous challenges. With continuing R&D cuts, both in the workforce and financially, and compound attrition at all stages, productivity is low and efficiency is of paramount importance. Eliminating drugs from the development pipeline that don’t show promise early on has become essential to drug development activities.
With long-term alliances, innovative partnerships and strategic M&A's abound, it seems taking a new approach to R&D methodologies and outsourcing activities is proving to be the solution of choice for most companies to bring new therapeutics to market.

Our Key Speakers Include:
• Georgi Georgiev, Manager, Clinical Research, AstraZeneca
• Yiping Chen, MRC Study Coordinator & Senior Investigator Scientist, University of Oxford
• Helen McGrath, Senior Clinical Site Manager and Co-lead of Global Hub Outsourcing Specialist Team, Bristol-Myers Squibb
• Pasi Piitulainen, Senior Director, Business & Science Affairs, Actelion
• John Mellelieu, Senior Manager, Contracts and Outsourcing, Allergan
• Tony Carita, Director Clinical Outsourcing, Otsuka US
• Amy Ylisaari, Head of In and Out Sourcing, Orion Pharma

Key topics to be addressed include:
• Identifying risks in partnership formation
• A new approach to CRO partnerships
• Assessing the challenges for biotech in developing a clinical outsourcing strategy
• Improving CRO negotiations to accelerate time to market
• The role and outcome of multi-vendor studies
• Building a successful and strong outsourcing partnership
• Facilitating early phase patient based commercial clinical trials

Visit to secure your place now!
Alternatively, contact Mohammad Saffaf at Tel: +44 (0) 207 827 6022 or Email: